| 000 | 01200 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517234735.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2398-502X | ||
| 024 | 7 |
_a10.12688/wellcomeopenres.14691.1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCresswell, Fiona V | |
| 245 | 0 | 0 |
_aHigh dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study). _h[electronic resource] |
| 260 |
_bWellcome open research _c2018 |
||
| 300 |
_a83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aSsebambulidde, Kenneth | |
| 700 | 1 | _aGrint, Daniel | |
| 700 | 1 | _aTe Brake, Lindsey | |
| 700 | 1 | _aMusabire, Abdul | |
| 700 | 1 | _aAtherton, Rachel R | |
| 700 | 1 | _aTugume, Lillian | |
| 700 | 1 | _aMuzoora, Conrad | |
| 700 | 1 | _aLukande, Robert | |
| 700 | 1 | _aLamorde, Mohammed | |
| 700 | 1 | _aAarnoutse, Rob | |
| 700 | 1 | _aMeya, David | |
| 700 | 1 | _aBoulware, David R | |
| 700 | 1 | _aElliott, Alison M | |
| 773 | 0 |
_tWellcome open research _gvol. 3 _gp. 83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.12688/wellcomeopenres.14691.1 _zAvailable from publisher's website |
| 999 |
_c28796221 _d28796221 |
||